RESUMEN
BACKGROUND AND AIM: Peroral endoscopic myotomy (POEM) is an established treatment for achalasia. In this systematic review and meta-analysis, we aimed to analyze the mid and long-term outcomes of POEM in esophageal motility disorders. METHODS: Literature search was performed in databases including PubMed, Embase, Cochrane databases, and Google scholar from January 2010 to May 2021. The primary objective of the study was the clinical success (Eckardt score ≤3 or <4) at mid-term (30 to 60 mo) and long-term (>60 mo) follow-up after POEM. Secondary objectives included post-POEM gastroesophageal reflux (GER) as evaluated by symptoms, increased esophageal acid exposure, and reflux esophagitis. RESULTS: Seventeen studies with 3591 patients were included in the review. Subtypes of motility disorders were type I (27%), type II (54.5%), type III (10.7%), distal esophageal spasm/Jackhammer esophagus (2%), and esophagogastric junction outflow obstruction (17.5%). Pooled mean follow-up duration was 48.9 months (95% CI, 40.02-57.75). Pooled rate of clinical success at mid-term follow-up was 87% (95% CI, 81-91; I2 , 86%) and long-term was 84% (95% CI, 76-89; I2 , 47%). In nonachalasia motility disorders (esophagogastric junction outflow obstruction, distal esophageal spasm, and Jackhammer esophagus), pooled rate of clinical success was 77% (95% CI, 65-85; I2 , 0%). GER as estimated by symptoms was 23% (95% CI, 19-27; I2 , 74%), erosive esophagitis was 27% (95% CI, 18-38%; I2 , 91%), and increased esophageal acid exposure was 41% (95% CI, 30-52; I2 , 88%). CONCLUSION: POEM is a durable treatment option in cases with achalasia. One-fourth of patients suffer from erosive GER in the long-term and success rates are lower in nonachalasia esophageal motility disorders.
Asunto(s)
Acalasia del Esófago , Trastornos de la Motilidad Esofágica , Espasmo Esofágico Difuso , Esofagitis Péptica , Reflujo Gastroesofágico , Miotomía , Cirugía Endoscópica por Orificios Naturales , Humanos , Acalasia del Esófago/cirugía , Acalasia del Esófago/complicaciones , Espasmo Esofágico Difuso/complicaciones , Resultado del Tratamiento , Trastornos de la Motilidad Esofágica/cirugía , Trastornos de la Motilidad Esofágica/complicaciones , Reflujo Gastroesofágico/complicaciones , Esofagitis Péptica/complicaciones , Esfínter Esofágico Inferior , EsofagoscopíaRESUMEN
BACKGROUND: There is limited data on long-term outcomes of per-oral endoscopic myotomy (POEM). In this study, we aim to evaluate the efficacy of POEM in patients who completed a minimum follow-up of 5 years. METHODS: Data of patients who underwent POEM and completed ≥ 5-year follow-up were analyzed, retrospectively. Primary outcome of study was clinical success (Eckardt ≤ 3) at ≥ 5 years after POEM. Secondary outcomes included predictors of dysphagia and symptomatic gastroesophageal reflux disease (GERD) on long-term follow-up. RESULTS: Three hundred nineteen patients (males 182, mean age 40.5 ± 14.2 years) completed a median of 73-(60-89) month follow-up. Esophageal motility disorders included idiopathic achalasia (type I 26.6%, type II 60.8%, type III 5.6%) and Jackhammer esophagus or distal esophageal spasm (2.8%). POEM was technically successful in 307 (96.2%) patients. Long-term success was 92.6% (overall), 92.1% (type I), 94.7% (type II), 87.5% (type III), and 75% (Jackhammer esophagus/distal esophageal spasm). Symptomatic GERD and reflux esophagitis were detected in 28.9% and 35.3% patients, respectively. On multivariate analysis, young age and female gender were independent risk factors for recurrent dysphagia (p = 0.037) and symptomatic GERD after POEM (p = 0.025), respectively. Lower post-POEM lower esophageal sphincter pressure was an independent predictor for reflux esophagitis (p = 0.016). CONCLUSION: POEM is an effective and durable treatment for achalasia and non-achalasia spastic motility disorders. Young patients and females may be at higher risk for recurrent dysphagia and symptomatic GERD, respectively.
Asunto(s)
Trastornos de Deglución , Acalasia del Esófago , Trastornos de la Motilidad Esofágica , Espasmo Esofágico Difuso , Esofagitis Péptica , Reflujo Gastroesofágico , Miotomía , Cirugía Endoscópica por Orificios Naturales , Adulto , Trastornos de Deglución/etiología , Trastornos de Deglución/cirugía , Acalasia del Esófago/complicaciones , Acalasia del Esófago/cirugía , Trastornos de la Motilidad Esofágica/complicaciones , Trastornos de la Motilidad Esofágica/cirugía , Espasmo Esofágico Difuso/complicaciones , Esfínter Esofágico Inferior/cirugía , Esofagitis Péptica/etiología , Femenino , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/cirugía , Humanos , Masculino , Persona de Mediana Edad , Cirugía Endoscópica por Orificios Naturales/efectos adversos , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
Distal esophageal spasm (DES) is a motility disorder characterized by premature contraction of the esophageal body during single swallows. It is thought to be due to impairment of esophageal inhibitory pathways, but studies to support this are limited. The normal response to multiple rapid swallows (MRS) is deglutitive inhibition of the esophageal body during the MRS sequence. Our aim was to compare the response to MRS in DES patients and healthy control subjects. Response to MRS during HRM was evaluated in 19 DES patients (8 with and 11 without concomitant esophagogastric junction outflow obstruction [EGJOO]) and 24 asymptomatic healthy controls. Patients with prior gastroesophageal surgery, peroral endoscopic myotomy, pneumatic dilation, esophageal botulinum toxin injection within 6 months of HRM, opioid medication use, and esophageal stricture were excluded. Response to MRS was evaluated for complete versus impaired inhibition (esophageal body contractility with distal contractile integral [DCI] > 100 mmHg-sec-cm during MRS), presence of post-MRS contraction augmentation (DCI post MRS greater than single swallow mean DCI), and integrated relaxation pressure (IRP). Impaired deglutitive inhibition during MRS was significantly more frequent in DES compared to controls (89% vs. 0%, P < 0.001), and frequency was similar for DES with versus without concomitant EGJOO (100% vs. 82%, P = 0.48). The proportion of subjects with augmentation post MRS was similar for both groups (37% vs. 38%, P = 1.00), but mean DCI post MRS was higher in DES than controls (3360.0 vs. 1238.9, P = 0.009). IRP was lower during MRS compared to single swallows in all patients, and IRP during MRS was normal in 5 of 8 patients with DES and EGJOO. Our study suggests that impaired deglutitive inhibition during MRS is present in the majority of patients with DES regardless of whether they have concomitant EGJOO, and future studies should explore the usefulness of incorporating response to MRS in the diagnosis of DES.
Asunto(s)
Trastornos de la Motilidad Esofágica , Espasmo Esofágico Difuso , Espasmo Esofágico Difuso/complicaciones , Unión Esofagogástrica , Humanos , Manometría , Estudios RetrospectivosRESUMEN
INTRODUCTION: Distal esophageal spasm (DES), a relatively rare condition, is characterized by simultaneous contractions of the distal esophagus and manifested by dysphagia and chest pain. Several treatment options are recommended, such as pharmacological therapy, endoscopic interventions, and surgical myotomy. Recently, per-oral endoscopic myotomy (POEM) has been adopted as an effective and less-invasive treatment due to its excellent short-term clinical outcomes. Nevertheless, few reports describe its long-term effects. CASE PRESENTATION: A 65-year-old woman complained of chest pain accompanied with dysphagia and weight loss for 4 months. A series of examinations suggested that she was suffering from DES and then POEM was performed. During the 2.5-year follow-up, we observed an exciting long-term outcome. Interestingly, hematoxylin and eosin staining verified a large number of eosinophils in the muscularis externa, which was absent in the mucosa of the esophagus of the patient. CONCLUSIONS: We herein report a case of DES who underwent POEM to eliminate persistent esophageal contractions. Eckardt score, esophageal emptying test, and high-resolution manometry were assumed to monitor the efficacy of POEM. During treatment and 2.5 years after operation, esophageal muscle biopsies and/or mucosal tissues were obtained. This case has been presented to describe that POEM could be a strategy for DES with a long-term curative effect and that eosinophils in the muscle layer of the esophagus might be involved in the pathogenesis of DES.âWhat is more, we reviewed literature to find similar cases reported in the past.
Asunto(s)
Trastornos de Deglución/etiología , Divertículo Esofágico/cirugía , Trastornos de la Motilidad Esofágica/cirugía , Espasmo Esofágico Difuso/diagnóstico por imagen , Espasmo Esofágico Difuso/cirugía , Esofagoscopía/métodos , Miotomía/métodos , Anciano , Trastornos de Deglución/diagnóstico , Divertículo Esofágico/complicaciones , Trastornos de la Motilidad Esofágica/fisiopatología , Espasmo Esofágico Difuso/complicaciones , Femenino , Humanos , Manometría , Resultado del TratamientoRESUMEN
Distal oesophageal spasm is a rare condition that affects the motility of the oesophagus. It can be diagnosed by highresolution oesophageal manometry and the diagnosis is supported by other modalities such as barium swallow and esophagogastroduodenoscopy examinations. Treatment options include pharmacological therapy, endoscopy and surgical interventions. We described a case of distal oesophageal spasm in an elderly patient who presented with chronic dyspepsia.
Asunto(s)
Espasmo Esofágico Difuso/diagnóstico , Esófago/fisiopatología , Reflujo Gastroesofágico/diagnóstico , Pirosis/diagnóstico , Anciano , Diagnóstico Diferencial , Espasmo Esofágico Difuso/complicaciones , Espasmo Esofágico Difuso/fisiopatología , Humanos , Masculino , Manometría , PresiónRESUMEN
Distal esophageal spasm is a rare motility disorder presenting principally with nonobstructive dysphagia and noncardiac chest pain. In symptomatic patients, the manometric diagnosis is made when >10% of the wet swallows have simultaneous and/or premature contractions intermixed with normal peristalsis. We characterize manometry and barium as complementary diagnostic approaches, and given the intermittent nature of the disorder, one should be always aware that it is almost impossible to rule out spasm. Treatment is difficult; we propose an approach beginning with the least invasive intervention.
Asunto(s)
Espasmo Esofágico Difuso/complicaciones , Espasmo Esofágico Difuso/terapia , Antidepresivos Tricíclicos/uso terapéutico , Radioisótopos de Bario , Toxinas Botulínicas/uso terapéutico , Bloqueadores de los Canales de Calcio/uso terapéutico , Acalasia del Esófago/complicaciones , Espasmo Esofágico Difuso/diagnóstico , Reflujo Gastroesofágico/complicaciones , Humanos , Dinitrato de Isosorbide/uso terapéutico , Manometría , Mentha piperita , Miotomía , Donantes de Óxido Nítrico/uso terapéutico , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Aceites de Plantas/uso terapéutico , Prevalencia , Inhibidores de la Bomba de Protones/uso terapéutico , Terminología como AsuntoAsunto(s)
Espasmo Esofágico Difuso/patología , Esófago/patología , Anciano de 80 o más Años , Dolor en el Pecho/etiología , Trastornos de Deglución/etiología , Dilatación , Espasmo Esofágico Difuso/complicaciones , Estenosis Esofágica/complicaciones , Estenosis Esofágica/patología , Estenosis Esofágica/terapia , Esofagoscopía , Reflujo Gastroesofágico/etiología , Humanos , Masculino , Pérdida de PesoRESUMEN
Distal esophageal spasm (DES) is a primary esophageal motility disorder. We encountered a rare case of DES accompanied by multiple esophageal diverticula. A 72-year-old woman complained of prolonged dysphagia and chest pain. A barium esophagogram showed multiple esophageal diverticula and significant contraction of the lower esophagus just above the cardia. Esophagogastroduodenoscopy revealed a corkscrew-like appearance, with spiral contractions and diverticula. High-resolution manometry revealed that the integrated relaxation pressure was normal; premature contractions were observed in ≥20% of the swallowing wave; the distal contractile integral was normal. She was diagnosed with DES according to the Chicago classification v 3.0. As smooth muscle relaxants were not effective, we decided to perform peroral endoscopic myotomy (POEM) to eliminate persistent esophageal contraction. After POEM treatment, her symptoms were markedly improved, and the Eckardt score significantly decreased from 11 points to 1. An esophagogram after POEM showed that barium flowed promptly into the stomach. The multiple esophageal diverticula were considered to be the result of false pulsion diverticulosis caused by excessive internal esophageal pressure, and this represented the most severe form of DES. POEM could be a new curative strategy for the most severe DES cases with multiple diverticula.
Asunto(s)
Divertículo Esofágico/cirugía , Espasmo Esofágico Difuso/cirugía , Esofagoscopía/métodos , Miotomía/métodos , Anciano , Divertículo Esofágico/complicaciones , Espasmo Esofágico Difuso/complicaciones , Femenino , Humanos , ManometríaRESUMEN
Autoimmune autonomic ganglionopathy (AAG) is an immune-mediated disorder that leads to various autonomic failures associated with anti-ganglionic acetylcholine receptor antibodies (anti-gAChR-Abs). Diffuse esophageal spasm (DES) is an uncommon esophageal motility disorder. We herein report the case of a 68-year-old woman with DES as a partial symptom of AAG. She presented with chronic esophageal transit failure, constipation, and numbness of the hands and feet, Adie's pupil, thermal hypoalgesia, and decreased deep tendon reflexes. Right sural nerve biopsy showed significantly decreased numbers of small myelinated fibers. Barium swallowing X-ray showed repetitive simultaneous contractions indicating DES in the esophagus. Gastrointestinal endoscopy and CT image showed a dilated esophageal lumen and liquid effusion. Simultaneously, serum anti-gAChR-α3-Ab indicating AAG was detected. After pulse intravenous methylprednisolone (IVMP) and intravenous immunoglobulin therapy (IVIg), the bolus progression and liquid effusion improved, suggesting that DES is an important gastrointestinal symptom of AAG.
Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/complicaciones , Enfermedades del Sistema Nervioso Autónomo/diagnóstico por imagen , Espasmo Esofágico Difuso/complicaciones , Espasmo Esofágico Difuso/diagnóstico por imagen , Ganglios Autónomos/diagnóstico por imagen , Anciano , Autoanticuerpos/sangre , Enfermedades del Sistema Nervioso Autónomo/sangre , Espasmo Esofágico Difuso/sangre , Femenino , HumanosRESUMEN
BACKGROUND AND AIMS: Spastic esophageal disorders (SEDs) include spastic achalasia (type III), diffuse esophageal spasm (DES), and nutcracker/jackhammer esophagus (JH). Per-oral endoscopic myotomy (POEM) has demonstrated efficacy and safety in the treatment of achalasia. Recently, POEM has been indicated for the treatment of SEDs. We conducted a systematic review and meta-analysis to determine the clinical success and safety of POEM in SEDs. METHODS: We searched several databases from 01/01/2007 to 01/10/2016 to identify studies (with five or more patients) on POEM for the treatment of SEDs. Weighted pooled rates (WPRs) for clinical success and adverse events (AEs) were calculated for all SEDs. Clinical success was defined as Eckardt scores of ≤3 and/or improvement in severity of dysphagia based on achalasia disease-specific health-related quality of life questionnaire. The WPRs for clinical success and AEs were analyzed using fixed- or random-effects model based on heterogeneity. The proportionate difference in clinical success and post-procedure adverse event rates among individual types of SEDs was also calculated. RESULTS: A total of eight observational studies with 179 patients were included in the final analysis. Two studies were of good quality and six were of fair quality based on the National Institutes of Health quality assessment tool. The WPR with 95% confidence interval (CI) for cumulative clinical success of POEM in all SEDs was 87% (78, 93%), I 2 = 37%. The total number of patients for individual disorders, i.e., type III achalasia, JH, and DES, was 116, 37, and 18, respectively. The WPRs for clinical success of POEM for type III achalasia, DES, and JH were 92, 88, and 72%, respectively. Proportion difference of WPR for clinical success was significantly higher for type III achalasia in comparison with JH (20%, P = 0.01). The WPR with 95% CI for AEs of POEM in all SEDs was 14% (9, 20%), I 2 = 0%. The WPRs for post-procedure adverse events for type III achalasia, DES, and JH were 11, 14, and 16%, respectively. There was no difference in safety of POEM among individual SEDs. CONCLUSION: POEM is an effective and safe therapeutic modality for the treatment of spastic esophageal disorders.
Asunto(s)
Trastornos de Deglución/cirugía , Acalasia del Esófago/cirugía , Espasmo Esofágico Difuso/cirugía , Esfínter Esofágico Inferior/cirugía , Trastornos de Deglución/etiología , Acalasia del Esófago/complicaciones , Trastornos de la Motilidad Esofágica/complicaciones , Trastornos de la Motilidad Esofágica/cirugía , Espasmo Esofágico Difuso/complicaciones , Esofagoscopía , Esófago/cirugía , Gastroscopía , Humanos , Cirugía Endoscópica por Orificios Naturales , Calidad de Vida , Resultado del TratamientoRESUMEN
We report the case of a 60-year-old woman with metastatic breast cancer whose intractable nausea and vomiting were effectively managed with a hyoscine hydrobromide (scopolamine) patch. Contrast swallow revealed oesophageal spasm to be the underlying cause. Symptom relief may be attributed to the antimuscarinic properties of the patch, allowing lower oesophageal sphincter relaxation. Following patch use she was able to enjoy small meals and fluids without symptoms. This is the first time this mechanism of action of scopolamine for alleviating nausea and vomiting has been described in the literature.
Asunto(s)
Neoplasias de la Mama/complicaciones , Espasmo Esofágico Difuso/complicaciones , Antagonistas Muscarínicos/uso terapéutico , Náusea/tratamiento farmacológico , Escopolamina/uso terapéutico , Vómitos/tratamiento farmacológico , Administración Cutánea , Neoplasias de la Mama/secundario , Femenino , Humanos , Persona de Mediana Edad , Antagonistas Muscarínicos/administración & dosificación , Náusea/etiología , Escopolamina/administración & dosificación , Resultado del Tratamiento , Vómitos/etiologíaAsunto(s)
Dolor en el Pecho/etiología , Espasmo Esofágico Difuso/diagnóstico , Espasmo Esofágico Difuso/cirugía , Esófago/patología , Adulto , Trastornos de Deglución/etiología , Diagnóstico Diferencial , Espasmo Esofágico Difuso/complicaciones , Esfínter Esofágico Inferior/fisiopatología , Esofagectomía , Esófago/fisiopatología , Humanos , Masculino , Dolor Intratable/etiología , Periodo Posprandial , Pérdida de PesoRESUMEN
BACKGROUND & AIMS: Endoscopic injection of botulinum toxin (BTX) has shown benefits for patients with diffuse esophageal spasm (DES) and nutcracker esophagus (NE) in small uncontrolled trials. We investigated the effect of BTX on symptoms of patients with DES or NE and assessed manometry findings in a prospective, double-blind, randomized, controlled study. METHODS: We assessed 22 patients with dysphagia-predominant, manometry-confirmed DES or NE (6 men; age, 63 ± 2 y) at a tertiary care medical center. Patients were given injections of BTX (8 × 12.5 U) or saline (8 × 0.5 mL) in 4 quadrants, at 2 and 7 cm above the esophagogastric junction. After 1 month, patients crossed over between groups and received endoscopic injections of BTX or saline. When the study began and 4 weeks after each injection, the patients were assessed by esophageal manometry and completed a symptom questionnaire (to determine solid and liquid dysphagia, chest pain, and regurgitation and heartburn; all scored 0-4). Responders were defined based on modified Vantrappen criteria for achalasia. RESULTS: After BTX injections, patients had significant decreases in total symptom scores (sum of solid and liquid dysphagia and chest pain; from 7.6 ± 0.7 to 4.8 ± 0.8; P = .01); this decrease was not observed in patients who received saline injections. Moreover, BTX injection stabilized unintentional weight loss (weight gain of 0.3 ± 0.3 after BTX injection vs further weight loss of 1.6 ± 0.5 kg after saline injection; P = .01). Fifty percent of patients had a response 1 month after BTX injection, compared with 10% after saline injection (P = .04); 30% still had a response 1 year after BTX injection. BTX injection also caused a significant decrease in the mean esophagogastric junction pressure, compared with baseline (15.8 ± 1.7 vs 24.0 ± 2.8 mm Hg; P = .02). CONCLUSIONS: In a prospective controlled study of patients with DES and NE, injections of BTX reduced symptoms and stabilized unintentional weight loss. TRIAL REGISTRY: http://www.targid.eu, ML2669, ML6294.
Asunto(s)
Toxinas Botulínicas/uso terapéutico , Trastornos de Deglución/tratamiento farmacológico , Trastornos de la Motilidad Esofágica/complicaciones , Espasmo Esofágico Difuso/complicaciones , Adulto , Anciano , Método Doble Ciego , Endoscopía/métodos , Femenino , Humanos , Masculino , Manometría , Persona de Mediana Edad , Estudios Prospectivos , Encuestas y Cuestionarios , Resultado del TratamientoRESUMEN
The progression of certain primary esophageal motor disorders to achalasia has been documented; however, the true incidence of this decay is still elusive. This study aims to evaluate: (i) the incidence of the progression of diffuse esophageal spasm to achalasia, and (ii) predictive factors to this progression. Thirty-five patients (mean age 53 years, 80% females) with a manometric picture of diffuse esophageal spasm were followed for at least 1 year. Patients with gastroesophageal reflux disease confirmed by pH monitoring or systemic diseases that may affect esophageal motility were excluded. Esophageal manometry was repeated in all patients. Five (14%) of the patients progressed to achalasia at a mean follow-up of 2.1 (range 1-4) years. Demographic characteristics were not predictive of transition to achalasia, while dysphagia (P= 0.005) as the main symptom and the wave amplitude of simultaneous waves less than 50 mmHg (P= 0.003) were statistically significant. In conclusion, the transition of diffuse esophageal spasm to achalasia is not frequent at a 2-year follow-up. Dysphagia and simultaneous waves with low amplitude are predictive factors for this degeneration.
Asunto(s)
Acalasia del Esófago/fisiopatología , Espasmo Esofágico Difuso/fisiopatología , Trastornos de Deglución/etiología , Progresión de la Enfermedad , Acalasia del Esófago/complicaciones , Espasmo Esofágico Difuso/complicaciones , Monitorización del pH Esofágico , Femenino , Estudios de Seguimiento , Pirosis/etiología , Humanos , Masculino , Manometría , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Factores de RiesgoAsunto(s)
Toxinas Botulínicas/administración & dosificación , Diagnóstico por Imagen/métodos , Eritromicina/administración & dosificación , Espasmo Esofágico Difuso , Obstrucción de la Salida Gástrica/diagnóstico , Gastroparesia , Adulto , Antidiscinéticos/administración & dosificación , Deglución/efectos de los fármacos , Diagnóstico Diferencial , Técnicas de Diagnóstico del Sistema Digestivo , Manejo de la Enfermedad , Nutrición Enteral/métodos , Espasmo Esofágico Difuso/complicaciones , Espasmo Esofágico Difuso/diagnóstico , Espasmo Esofágico Difuso/fisiopatología , Espasmo Esofágico Difuso/terapia , Fármacos Gastrointestinales/administración & dosificación , Motilidad Gastrointestinal/efectos de los fármacos , Gastroparesia/complicaciones , Gastroparesia/diagnóstico , Gastroparesia/fisiopatología , Gastroparesia/terapia , Humanos , Masculino , Resultado del TratamientoRESUMEN
Diffuse esophageal spasm (DES) remains insufficiently understood. Here we aimed to summarize the demographic, clinical, radiographic, and manometric features in a large cohort of patients with DES. We identified all consecutive patients diagnosed with DES from 2000 to 2006 at Mayo Clinic Florida. The computerized records of these patients were reviewed to extract relevant information. We performed 2654 esophageal motilities during that period. There were 108 patients with esophageal spasm, and 55% were female. Median age was 71 years. The most common leading symptom was dysphagia in 55, followed by chest pain in 31. Weight loss occurred in 28 patients. The median of time from onset of symptoms to diagnosis was 48 months (range 0-480), with a median of time from the first medical consultation to diagnosis of 8 months (range 0-300). The most frequent comorbidities were hypertension and psychiatric problems. At presentation, 81 patients were taking acid-reducing medications, and 49 patients were taking psychotropic drugs. An abnormal esophagogram was noted in 46 of 76 patients with this test available, but most radiographic findings were nonspecific with the typical 'corkscrew' appearance seen in only three patients. Gastroesophageal reflux disease (GERD) was diagnosed by pH testing or endoscopy in 41 patients. We did not find any difference between the rate of simultaneous contractions or esophageal amplitude between patients with a leading symptom of dysphagia and those with chest pain. DES is an uncommon motility disorder that often goes unrecognized for years. Physicians should be aware of the clinical heterogeneity of DES and consider motility testing early in the course of unexplained esophageal symptoms. Given the high prevalence of GERD in DES, the role of GERD and the impact of acid-reducing therapy in DES deserve further study.